We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Amneal Pharmaceuticals Holding Co | NYSE:AMRX | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 5.87 | 0 | 01:00:00 |
*
|
The remainder of this cover page shall be filled out for a reporting person
’
s initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
|
CUSIP No. 03168L105
|
|
13D
|
|
Page 1 of 3 pages
|
1
|
|
Names of Reporting Persons
Chintu Patel
|
||||
2
|
|
Check the Appropriate Box if a Member of a Group
(a)
☒
(b)
☐
|
||||
3
|
|
SEC Use Only
|
||||
4
|
|
Source of Funds (See Instructions)
OO
|
||||
5
|
|
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
☐
|
||||
6
|
|
Citizenship or Place of Organization
United States
|
||||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH:
|
|
7
|
|
Sole Voting Power
24,784,336
|
||
|
8
|
|
Shared Voting Power
0
|
|||
|
9
|
|
Sole Dispositive Power
24,784,336
|
|||
|
10
|
|
Shared Dispositive Power
0
|
|||
11
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
24,784,336
|
||||
12
|
|
Check if the Aggregate Amount in Row (11) Excludes Certain Shares
☐
|
||||
13
|
|
Percent of Class Represented by Amount in Row (11)
8.3%
(1)
|
||||
14
|
|
Type of Reporting Person
IN
|
CUSIP No. 03168L105
|
|
13D
|
|
Page 2 of 3 pages
|
CUSIP No. 03168L105
|
|
13D
|
|
Page 3 of 3 pages
|
|
|
/s/ Chintu Patel
|
|
Chintu Patel
|
|||
|
|||
1 Year Amneal Pharmaceuticals Chart |
1 Month Amneal Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions